Search results for: 'systems integrators'

COVID-19 has crippled the global supply chain and forced most countries to take preventative measures by closing down their economies. While the pandemic has shown no signs of slowing down globally, cities, states, and countries are slowly emerging from lock downs and are stumbling into the new reality. Global economies are currently in a recession...

06 Sep 2021  |  Global  |  Frost Radar

Frost Radar™: Global Airport Digitalization Market, 2020

A Benchmarking System to Spark Companies to Action - Innovation That Fuels Growth Pipelines

Infographics

×

The airport digitalization market is fragmented, with numerous start-ups and conglomerates offering IT solutions. Leading companies have distinguished their products and services by developing next-generation technological capabilities, bundling and upselling solutions, and creating cross-industry synergies. The competitive environment, however, is...

The automotive industry is experiencing a significant transformation, transitioning from conventional to software-defined vehicles. As vehicles develop into intelligent, connected platforms driven by electrification, autonomous driving technologies, and digital services, traditional original equipment manufacturers (OEMs) are confronted with increa...

18 Dec 2020  |  Global  |  Market Research

Digital Transformation to Drive Growth in the Global Airport Information Technology, 2025

Airports Need to Embrace Digital Transformation to Enhance Passenger Experience and Improve Cost Efficiencies

Infographics

×

Airports need to embrace digital transformation to enhance the passenger experience and improve cost efficiencies. This research service will focus on the global airport information technology market across the various Tiers of airports (5 Tiers in total) and across 6 key regions, Africa, Asia-Pacific, Europe, the Middle East, Latin America, and No...

The global space industry has been expanding with the entry of new participants and non-space companies that are extending their roles to cater to both the upstream and the downstream segments. The upstream segment is expanding exponentially and is seeing successful launches by low earth orbit (LEO) satellite constellation operators as well as plan...

11 Nov 2020  |  Global  |  Frost Radar

Frost Radar™: Global Airline IT Market, 2020

A Benchmarking System to Spark Companies to Action–Innovation That Fuels New Deal Flow and Growth Pipelines

Infographics

×

The airline information technology (IT) market is a highly fragmented one with numerous start-ups and conglomerates offering various airline IT solutions across geographies. The leading companies in this market have distinguished their products and services from the rest of the market by maintaining a long-term focus in their R&D investment strateg...

25 May 2021  |  North America  |  Frost Radar

Frost Radar™: North American Enterprise Cloud Contact Center Market, 2021

A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

The global cloud contact center market generated $2.7 billion in 2019, recording 15.4% growth year-over-year from 2018. Revenue will increase at a 15.3% compound annual growth rate to reach $7.4 billion by 2026. Small and medium-sized contact centers have been steadily migrating to cloud-based technologies; the expansion of hybrid cloud offerings a...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

25 Apr 2022  |  North America  |  Frost Radar

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...